DNA X, Inc. — Form 8-K/A
Filed August 13, 2026 · analyzed by the 8-K Agent
8-K/A
— Neutral
significance 28/100
What the filing says
DNA X filed an amended 8-K (Form 8-K/A) on August 13, 2026, relating to an unregistered sale of equity securities reported in Item 3.02 (period of report June 29, 2026). The filing does not disclose specific dollar amounts, share counts, prices, or counterparty names in the metadata provided. The amendment suggests a prior disclosure required correction, but substantive details of the equity transaction are absent from this summary.
Why this rating
Amended disclosure of equity issuance lacks dollar/share specifics. Routine administrative correction for $12.6M market-cap company; material only if proceeds or dilution were sizable—not evident here.
Extracted items
See more from August 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.